Regulatory T-cells and preeclampsia: An overview of literature

Expert Review of Clinical Immunology

Volumn 12, Issue 2, 2016, Pages 209-227

  Rahimzadeh, Mahsa ^a   Norouzian, Marzieh ^a   Arabpour, Fahimeh ^a   Naderi, Nadereh ^a  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immune tolerance; Preeclampsia; Pregnancy; Regulatory T cell; Systematic review

Indexed keywords

CORTICOSTEROID; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; MEDLINE; PREECLAMPSIA; REGULATORY T LYMPHOCYTE; REVIEW; SCOPUS; SYSTEMATIC REVIEW; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; PREGNANCY;

FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES, REGULATORY;

EID: 84957441574     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2016.1105740     Document Type: Review

References (154)

1. Ahn H, Park J, Gilman-Sachs A, et al. Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol. 2011;65(4):377-394.
2. Brown MA, Lindheimer MD, De Swiet M, et al. The classification and Diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):ix-xiv.
3. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reproductive Biomedicine Online. 2006;13(5):680-686.
4. Zenclussen AC, editor. Regulatory T cells in pregnancy. Springer seminars in immunopathology. Springer; 2006;28 (1):31-39.
5. Saito S, Tsukaguchi N, Hasegawa T, et al. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reproductive Immunol (New York, NY : 1989). 1999;42(4):240-245. Epub 1999 Dec 2.
6. Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999;117(3):550-555. Epub 1999 Sep 1.
7. Somerset DA, Zheng Y, Kilby MD, et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112(1):38-43.
8. Zhao J-X, Zeng Y-Y, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4+ CD25+ regulatory T cell pool during pregnancy. J Reprod Immunol. 2007;75(2):71-81.
9. Sasaki Y, Sakai M, Miyazaki S, et al. Decidual and peripheral blood CD4+ CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10 (5):347-353.
10. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells meDiate maternal tolerance to the fetus. Nat Immunol. 2004;5 (3):266-271.
11. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531-564.
12. Adeegbe DO, Nishikawa H. Natural and induced T regulatory cells in cancer. Front Immunol. 2013;4:190. Epub 2013 Jul 23.
13. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol. 2007;196(1):5. e1-5. e7.
14. Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet. 2005;365(9461):785-799.
15. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al. Proportion of peripheral blood and decidual CD4+ CD25bright regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007;149(1):139-145.
16. Saito S, Umekage H, Sakamoto Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reproductive Immunol (New York, NY : 1989). 1999;41(5):297-306. Epub 1999 Jun 23.
17. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1ddependent NKT cells. J Clin Invest. 2004;114(10):1379-1388. Epub 2004 Nov 17.
18. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol. 2006;27(9):399-404.
19. Ghiringhelli F, François G, Cédric M, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-bdependent manner. J Exp Med. 2005;202:1075-1085.
20. Azuma T, Takahashi T, Kunisato A, et al. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res. 2003;63(15):4516-4520. Epub 2003 Aug 9.
21. Fehérvári Z, Sakaguchi S. Control of Foxp3+ CD25+ CD4+ regulatory cell activation and function by dendritic cells. Int Immunol. 2004;16(12):1769-1780.
22. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061.
23. Maggi E, Cosmi L, Liotta F, et al. Thymic regulatory T cells. Autoimmun Rev. 2005;4(8):579-586.
24. Van Oosterhout A, Bloksma N. Regulatory T-lymphocytes in asthma. Eur Respir J. 2005;26(5):918-932.
25. Lin W, Haribhai D, Relland LM, et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol. 2007;8(4):359-368.
26. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells. Int Immunol. 2004;16(11):1643-1656.
27. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4+ CD25+ Immunoregulatory T Cells: Gene Expression Analysis Reveals a Functional Role for the Glucocorticoid-Induced TNF Receptor. Immunity. 2002;16(2):311-323.
28. Darmochwal-Kolarz D, Saito S, Rolinski J, et al. Activated T Lymphocytes in Pre-Eclampsia. Am J Reprod Immunol. 2007;58(1):39-45.
29. Hu D, Chen Y, Zhang W, et al. Alteration of peripheral CD4+ CD25+ regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand. 2008;87(2):190-194.
30. Mahmoud F, Omu A, Abul H, et al. Lymphocyte subpopulations in pregnancy complicated by hypertension. J Obstetrics Gynecol. 2003;23(1):20-26.
31. Paeschke S, Chen F, Horn N, et al. Preeclampsia is not Associated with Changes in the Levels of Regulatory T Cells in Peripheral Blood. Am J Reprod Immunol. 2005;54(6):384-389.
32. Sakaguchi S, Sakaguchi N, Asano M, et al. Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995. J Immunol (Baltimore, Md: 1950). 2011;186(7):3808-3821. Epub 2011 Mar 23.
33. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-384. Epub 1998 Oct 9.
34. Shan J, Guo Y, Luo L, et al. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol. 2011;270(1):5-12. Epub 2011 Jun 7.
35. Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol. 2010;54(2-3):281-294. Epub 2009 Oct 31.
36. Cerdeira AS, Kopcow HD, Karumanchi SA. Regulatory T cells in preeclampsia: some answers, more questions? Am J Pathol. 2012;181(6):1900-1902. Epub 2012 Oct 16.
37. Chaouat G. Effectors regulatory T cells in pregnancy (and autoimmunity?). Expert Rev Clin Immunol. 2007;3(6):861-869. Epub 2007 Nov 1.
38. Clark DA. Immunological factors in pregnancy wastage: fact or fiction. Am J Reproductive Immunol. (New York, NY : 1989) 2008;59(4):277-300. Epub 2008 Mar 14.
39. Clark DA, Chaouat G. Regulatory T cells and reproduction: how do they do it? J Reprod Immunol. 2012;96(1-2):1-7. Epub 2012 Oct 2.
40. Darmochwal-Kolarz D, Kludka-Sternik M. The immunoregulatory disturbances in the pathogenesis of pre-eclampsia. Archives Perinatal Medicine. 2010;16 (2):67-73.
41. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009;15 (5):517-535. Epub 2009 Mar 13.
42. Guleria I, SayeghMH. Maternal acceptance of the fetus: true human tolerance. J Immunol (Baltimore,Md: 1950). 2007;178 (6):3345-3351. Epub 2007 Mar 7.
43. Hahn S. Immunopathology of pregnancy and conception. Semin Immunopathol. 2007;29(2):81.
44. Hahn S, Hasler P, Hoesli I, et al. Preeclampsia: Does it involve an imbalance in regulatory immune cells? Expert Rev Obstetrics Gynecol. 2010;5(2):165-168.
45. Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014;5:125. Epub 2014 Apr 16.
46. Jiang TT, Chaturvedi V, Ertelt JM, et al. Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J Immunol (Baltimore, Md: 1950). 2014;192 (11):4949-4956. Epub 2014 May 20.
47. Schjenken JE, Tolosa JM, Paul JW, et al. Mechanisms of maternal immune tolerance during pregnancy. In: Zheng J, editor. Recent advances in research on the human placenta. 2012;211-242. doi:10. 5772/33541.
48. Kumpel BM, Manoussaka MS. Placental immunology and maternal alloimmune responses. Vox Sang. 2012;102(1):2-12. Epub 2011 Sep 3.
49. Lamarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 2010;62(2):105-120. Epub 2010 May 27.
50. Laresgoiti-Servitje E. A leaDing role for the immune system in the pathophysiology of preeclampsia. J Leukoc Bio. 2013;94(2):247-257.
51. Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16(5):510-524. Epub 2010 Apr 15.
52. Leber A, Teles A, Zenclussen AC. REVIEW ARTICLE: Regulatory T Cells and Their Role in Pregnancy. Am J Reprod Immunol. 2010;63(6):445-459.
53. Lee SK, Kim JY, Lee M, et al. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reproductive Immunol (New York, NY : 1989). 2012;67(4):311-318. Epub 2012 Mar 3.
54. Munoz-Suano A, Hamilton AB, Betz AG. Gimme shelter: the immune system during pregnancy. Immunol Rev. 2011;241 (1):20-38. Epub 2011 Apr 15.
55. Nevers T, Kalkunte S, Sharma S. Uterine Regulatory T cells, IL-10 and hypertension. Am J Reproductive Immunol (New York, NY : 1989). 2011;66(Suppl 1):88-92 Epub 2011 Jul 8.
56. Norris W, Nevers T, Sharma S, et al. Review: hCG, preeclampsia and regulatory T cells. Placenta. 2011;32(Suppl 2): S182-5. Epub 2011 Feb 8.
57. Perez-Sepulveda A, Torres MJ, Khoury M, et al. Innate immune system and preeclampsia. Front Immunol. 2014;5:244. Epub 2014 Jun 7.
58. Quinn KH, Parast MM. Decidual regulatory T cells in placental pathology and pregnancy complications. Am J Reproductive Immunol (New York, NY : 1989). 2013;69(6):533-538. Epub 2013 Feb 7.
59. Redman CW, Sargent IL. REVIEW ARTICLE: Immunology of Pre-Eclampsia. Am J Reprod Immunol. 2010;63(6):534-543.
60. Robertson SA, Guerin LR, Moldenhauer LM, et al. Activating T regulatory cells for tolerance in early pregnancy-the contribution of seminal fluid. J Reprod Immunol. 2009;83(1-2):109-116. Epub 2009 Oct 31.
61. Robillard PY, Dekker G, Chaouat G. Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop? J Reprod Immunol. 2014;101-102:62-69. Epub 2013 Aug 27.
62. Robillard PY, Dekker G, Chaouat G, et al. Epidemiological studies on primipaternity and immunology in preeclampsia-a statement after twelve years of workshops. J Reprod Immunol. 2011;89(2):104-117. Epub 2011 May 6.
63. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol. 2010;88 (6):615-617. Epub 2010 May 26.
64. Saito S, Shiozaki A, Nakashima A, et al. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28 (2):192-209.
65. Saito S, Nakashima A, Shima T, et al. Th1/ Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reproductive Immunol (New York, NY : 1989). 2010;63(6):601-610. Epub 2010 May 12.
66. Saito S, Sakai M, Sasaki Y, et al. Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol. 2007;76(1-2):30-39. Epub 2007 Oct 16.
67. Saito S, Shima T, Inada K, et al. Which types of regulatory T cells play important roles in implantation and pregnancy maintenance? Am J Reproductive Immunol (New York, NY : 1989). 2013;69(4):340-345. Epub 2013 Feb 26.
68. Saito S, Shima T, Nakashima A, et al. What is the role of regulatory T cells in the success of implantation and early pregnancy? J Assist Reprod Genet. 2007;24(9):379-386. Epub 2007 Aug 2.
69. Sanguansermsri D, Pongcharoen S. Pregnancy immunology: decidual immune cells. Asian Pac J Allergy Immunol. 2008;26(2-3):171-181. Epub 2008 Dec 6.
70. Staff AC, Johnsen GM, Dechend R, et al. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol. 2014;101-102:120-126. Epub 2013 Oct 15.
71. Teles A, Thuere C, Wafula PO, et al. Origin of Foxp3(+) cells during pregnancy. Am J Clin Exp Immunol. 2013;2 (3):222-233. Epub 2013 Nov 2.
72. Teles A, Zenclussen AC, Schumacher A. Regulatory T cells are baby's best friends. Am J Reproductive Immunol (New York, NY : 1989). 2013;69(4):331-339. Epub 2013 Jan 8.
73. Terness P, Kallikourdis M, Betz AG, et al. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reproductive Immunol (New York, NY : 1989). 2007;58(3):238-254. Epub 2007 Aug 8.
74. Tilburgs T, Claas FH, Scherjon SA. Elsevier Trophoblast Research Award Lecture: Unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta. 2010;31(Suppl):S82-6. Epub 2010 Jan 29.
75. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol. 2006;7(3):241-246. Epub 2006 Feb 17.
76. Verlohren S, Muller DN, Luft FC, et al. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension. 2009;54(3):439-443. Epub 2009 Jul 15.
77. Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia-the same basic mechanism? Hum Immunol. 2006;67(7):492-511. Epub 2006 Jul 11.
78. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol. 2013;69(4):291-303.
79. Zenclussen AC, Schumacher A, Zenclussen ML, et al. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus. Expert Rev Mol Med. 2007;9(10):1-14. Epub 2007 Apr 28.
80. Hsu P, Santner-Nanan B, Dahlstrom JE, et al. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. 2012;181(6):2149-2160. Epub 2012 Oct 16.
81. Miko E, Szereday L, Barakonyi A, et al. Immunoactivation in preeclampsia: Vdelta2+ and regulatory T cells during the inflammatory stage of disease. J Reprod Immunol. 2009;80(1-2):100-108. Epub 2009 Apr 28.
82. Toldi G, Rigo J Jr., Stenczer B, et al. Increased prevalence of IL-17-producing peripheral blood lymphocytes in preeclampsia. Am J Reproductive Immunol (New York, NY 1989). 2011;66(3):223-229. Epub 2011 Feb 11.
83. Toldi G, Saito S, Shima T, et al. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25-FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reproductive Immunol (New York, NY : 1989). 2012;68(2):175-180. Epub 2012 Apr19.
84. Toldi G, ͈vec P, Vásárhelyi B, et al. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand. 2008;87 (11):1229-1233.
85. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reproductive Immunol. 2012;93 (2):75-81.
86. Darmochwal-Kolarz D, Saito S, Tabarkiewicz J, et al. Apoptosis Signaling Is Altered in CD4(+)CD25(+) FoxP3(+) T Regulatory Lymphocytes in Pre-Eclampsia. Int J Mol Sci. 2012;13 (6):6548-6560. Epub 2012 Jul 28.
87. Steinborn A, Haensch GM, Mahnke K, et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol (Orlando, FL). 2008;129(3):401-412. Epub 2008 Sep 23.
88. Steinborn A, Schmitt E, Kisielewicz A, et al. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol. 2012;167(1):84-98.
89. Santner-Nanan B, Peek MJ, Khanam R, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol (Baltimore, Md : 1950). 2009;183 (11):7023-7030. Epub 2009 Nov 17.
90. Hafeez NA, Fouda Mel T, Abdel Gawad ER, et al. The role of regulatory T cells in preeclampsia. Egypt J Immunol. 2014;21 (1):45-55. Epub 2014 Sep 11.
91. Moreno-Eutimio MA, Tovar-Rodriguez JM, Vargas-Avila K, et al. Increased serum levels of inflammatory meDiators and low frequency of regulatory T cells in the peripheral blood of preeclamptic Mexican women. Biomed Res Int. 2014;2014:413249. Epub 2015 Jan 13.
92. Prins JR, Boelens HM, Heimweg J, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertension in pregnancy. Off J Int Soc Study Hypertens Pregnancy. 2009;28(3):300-311. Epub 2009 May 05.
93. Zeng B, Kwak-Kim J, Liu Y, et al. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation. Am J Reproductive Immunol (New York, NY : 1989). 2013;70(6):454-463. Epub 2013 Sep 17.
94. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30(6):899-911. Epub 2009 May 26.
95. Hennessy A, Pilmore H, Simmons L, et al. A deficiency of placental IL-10 in preeclampsia. J Immunol. 1999;163 (6):3491-3495.
96. Jonsson Y, Matthiesen L, Berg G, et al. Indications of an altered immune balance in preeclampsia: a decrease in in vitro secretion of IL-5 and IL-10 from blood mononuclear cells and in blood basophil counts compared with normal pregnancy. J Reproductive Immunol. 2005;66 (1):69-84.
97. Dong M, He J, Wang Z, et al. Placental imbalance of Th1-and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand. 2005;84(8):788-793.
98. Wegmann TG, Lin H, Guilbert L, et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH 2 phenomenon? Immunol Today. 1993;14 (7):353-356.
99. Rowe JH, Ertelt JM, Xin L, et al. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 2012;490(7418):102-106. Epub 2012 Oct 2.
100. Shima T, Sasaki Y, Itoh M, et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. 2010;85(2):121-129. Epub 2010 May 5.
101. Saito S, Sasaki Y, Sakai M. CD4+ CD25high regulatory T cells in human pregnancy. J Reprod Immunol. 2005;65 (2):111-120.
102. Tilburgs T, Roelen D, Van Der Mast B, et al. Differential Distribution of CD4+ CD25bright and CD8+ CD28? T-cells in Decidua and Maternal Blood During Human Pregnancy. Placenta. 2006;27:47-53.
103. Heikkinen J, Möttönen M, Alanen A, et al. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004;136 (2):373-378.
104. August P, Marcaccio B, Gertner JM, et al. 1, 25-dihydroxyvitamin D metabolism in preeclampsia. Am J Obstet Gynecol. 1992;166(4):1295-1299.
105. Salustiano EM, De Pinho JC, Provost K, et al. Maternal serum hormonal factors in the pathogenesis of preeclampsia. ObstetGynecolSurv. 2013 Feb;68 (2):141-150.
106. Mizutani SEM. New insights into the role of sex steroid hormones in pregnancy: possible therapeutic approach by sex steroid hormones for the treatment of both preeclampsia and preterm labor. Exp Clin Endocrinol Diabetes. 2015;123 (3):159-164.
107. Dalamaga M, Srinivas SK, Elovitz MA, et al. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study. Metabolism. 2011;60(11):1539-1544.
108. Arruvito L, Sanz M, Banham AH. L. F. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol (Baltimore, Md : 1950). 2007;178 (4):2572-2578.
109. Taylor A, Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol. 2001;79(4):358-367.
110. Shirshev SV, Orlova EG, Zamorina SA, et al. Influence of reproductive hormones on the induction of CD4(+)CD25 (bright)Foxp (3+) regulatory T cells. Doklady biological sciences. ProceeDings of the Academy of Sciences of the USSR, Biological Sciences Sections / Translated from Russian. 2011;440:343-346. Epub 2011 Dec 3.
111. De Rosa V, Procaccini C, Cali G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity. 2007;26(2):241-255. Epub 2007 Feb 20.
112. Schumacher A, Poloski E, Spörke D, et al. Luteinizing hormone contributes to fetal tolerance by regulating adaptive immune responses. Am J ReprodImmunol. 2014;71(5):434-440.
113. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology. 2006;118(1):58-65.
114. Polanczyk MJ, Carson BD, Subramanian S, et al. Cutting edge: estrogen drives expansion of the CD4+ CD25+ regulatory T cell compartment. The. J Immunol. 2004;173(4):2227-2230.
115. Zeisler H, Jirecek S, Hohlagschwandtner M, et al. Concentrations of estrogens in patients with preeclampsia. Wien Klin Wochenschr. 2002;114 (12):458-461.
116. Poston L, editor. Leptin and preeclampsia. Seminars in reproductive medicine. New York (NY): Thieme Medical Publishers, Inc; 2002.
117. Sagawa N, Yura S, Itoh H, et al. Role of leptin in pregnancy-a review. Placenta. 2002;23:S80-S6.
118. Matarese G, Carrieri PB, La Cava A, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA. 2005;102(14):5150-5155.
119. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England J Med. 2006;355(10):992-1005.
120. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+ CD25? naive T cells to CD4+ CD25+ regulatory T cells by TGF-? induction of transcription factor Foxp3. J Exp Med. 2003;198 (12):1875-1886.
121. Chen W, Konkel JE. TGF-? and adaptive'Foxp3+ regulatory T cells. J Mol Cell Biol. 2010;2(1):30-36.
122. Luppi P, DeLoia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol. 2006;118(2):268-275.
123. Rusterholz C, Hahn S, Holzgreve W, editors. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol. 2007;29 (2):151-162.
124. Pasare C, Medzhitov R. Toll pathwaydependent blockade of CD4+ CD25+ T cell-meDiated suppression by dendritic cells. Science. 2003;299(5609):1033-1036.
125. Afzali B, Mitchell P, Lechler R, et al. Translational Mini-Review Series on Th17 Cells: Induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol. 2010;159(2):120-130.
126. Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat Rev Immunol. 2009;9(12):883-889.
127. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30(6):899-911.
128. Toldi G, Vasarhelyi ZE, Rigo J Jr., et al. Prevalence of Regulatory T-Cell Subtypes in Preeclampsia. Am J Reproductive Immunol (New York, NY : 1989). 2015;74(2):110-115. Epub 2015 Mar 31.
129. Schaier M, Seissler N, Schmitt E, et al. DRhigh+ CD45RA?-Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients. Plos One. 2012;7(3):e34208.
130. Kämmerer U, Eggert AO, Kapp M, et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol. 2003;162 (3):887-896.
131. Peng G, Guo Z, Kiniwa Y, et al. Toll-like receptor 8-meDiated reversal of CD4+ regulatory T cell function. Science. 2005;309(5739):1380-1384.
132. Yang Y, Huang C-T, Huang X, et al. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-meDiated CD8 tolerance. Nat Immunol. 2004;5(5):508-515.
133. Kim YM, Romero R, Oh SY, et al. Tolllike receptor 4: a potential link between danger signals, the innate immune system, and preeclampsia? Am J Obstet Gynecol. 2005;193(3):921. e1-. e8.
134. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today. 1999;20(3):114-118.
135. Visser N, Van Rijn BB, Rijkers GT, et al. Inflammatory changes in preeclampsia: current understanDing of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62 (3):191-201.
136. Wang CC, Yim KW, Poon TC, et al. Innate immune response by ficolin binDing in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem. 2007;53 (1):42-52.
137. Vacca P, Cantoni C, Vitale M, et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induc-tion of Tregs and immunosuppression. ProcNatlAcadSci USA. 2010;107(26):11918-11923.
138. Chen W, Liang X, Peterson AJ, et al. The indoleamine 2, 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol (Baltimore, Md : 1950). 2008;181(8):5396-5404.
139. Liu X, Liu Y, Ding M, et al. Reduced expression of indoleamine 2, 3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells. Mol Med Rep. 2011;4(1):53-58. Epub 2011 Apr 5.
140. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198(1):7-22.
141. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J. 2008;12(2):223-242.
142. Biglino A, Limone P, Forno B, et al. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. European J Endocrinol. 1995;133(2):173-179.
143. Burg E, Vernooy J, Cramer A, et al. Host Defense Againts Pneumonia: the Role Of The Leptin/neutrophil Axis. Am J Respir Crit Care Med. 2013;187:A5008.
144. Christeff N, Gharakhanian S, Thobie N, et al. Evidence for changes in adrenal and testicular steroids during HIV infection. JAIDS J Acquired Immune Deficiency Syndromes. 1992;5(8):841-846.
145. Klein S. Hormonal and immunological mechanisms meDiating sex differences in parasite infection. Parasite Immunol. 2004;26(6-7):247-264.
146. Roberts C, Satoskar A, Alexander J. Sex steroids, pregnancy-associated hormones and immunity to parasitic infection. Parasitology Today. 1996;12(10):382-388.
147. Sonstein J, Goel D, O'Brien E, et al. Leptin Is Required For Vaccine Induced Protection Against Pneumococcal Pneumonia. Am J Respir Crit Care Med. 2012;185:A3278.
148. Steinborn A, Sohn C, Sayehli C, et al. Preeclampsia a pregnancy-specific disease, is associated with fetal monocyte activation. Clin Immunol. 2001;100 (3):305-313.
149. Branch DW, Mitchell M, Miller E, et al. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet. 1994;343(8898):645-646.
150. Do Prado AD, Piovesan DM, Staub HL, et al. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstetrics Gynecol. 2010;116(6):1433-1443.
151. Shaarawy M, El-Mallah SY, El-Yamani AM. The prevalence of serum antineutrophil cytoplasmic autoantibodies in preeclampsia and eclampsia. J Soc Gynecol Investig. 1997;4 (1):34-39.
152. Siddiqui AH, Irani RA, Blackwell SC, et al. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia correlation with disease severity. Hypertension. 2010;55 (2):386-393.
153. Muzzio D, Zenclussen AC, Jensen F. The role of B cells in pregnancy: the good and the bad. Am J Reprod Immunol. 2013;69 (4):408-412.
154. Jensen F, Wallukat G, Herse F, et al. CD19+ CD5+ cells as indicators of preeclampsia. Hypertension. 2012;59 (4):861-868.